1. Homepagina
  2. Aandelen
  3. BelgiŽ
  4. Euronext Bruxelles
  5. Biocartis Group NV
  6. Nieuws
  7. Andere talen
    BCART   BE0974281132

BIOCARTIS GROUP NV

(BCART)
  Rapport
Real Time Euronext Bruxelles  -  09:43 19-08-2022
1.706 EUR   +0.59%
11/08Brussel noteert vlak
AM
11/08Brusselse beurs hoger geopend
AM
27/07Melexis uitblinker op groene Brusselse beurs
AM
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAndere talenPersberichtenOfficiŽle publicatiesSectornieuwsAnalyse MarketScreener
Nieuws in andere talen op BIOCARTIS GROUP NV
22/06ADRs End Lower; ArcelorMittal, AstraZeneca Trade Actively
22/06ASTRAZENECA : l'EMA accepte un dossier dans le cancer du sein
22/06Biocartis, AstraZeneca To Jointly Develop Companion Lung Cancer Diagnostic Test For Tag..
22/06PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces New Agreement with AstraZeneca for ..
22/06PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces New Agreement with AstraZeneca for ..
22/06Biocartis Group NV Announces New Agreement with Astrazeneca for the Development and Mar..
20/06Molecular Diagnostics Group Biocartis Introduces Lung Cancer Testing Panel
20/06PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Launch of its Rapid CE-marked IVD I..
20/06PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Launch of its Rapid CE-marked IVD I..
20/06Biocartis Group NV Announces Launch of its Rapid CE-marked IVD Idylla GeneFusion Panel ..
15/06PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Reaches Key Commercial Milestones: One-Millio..
15/06PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Reaches Key Commercial Milestones: One-Millio..
13/05PRESS RELEASE BIOCARTIS GROUP NV : Results of the Annual Shareholders' Meeting held on 13 ..
04/05PRESS RELEASE BIOCARTIS GROUP NV : New Study Led by Memorial Sloan Kettering Cancer Center..
04/05PRESS RELEASE BIOCARTIS GROUP NV : New Study Led by Memorial Sloan Kettering Cancer Center..
04/05Biocartis Group NV announces New Study Led by Memorial Sloan Kettering Cancer Center (N..
25/04PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Presentation of Three Idylla™..
25/04PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Presentation of Three Idylla™..
21/04PRESS NEWS BIOCARTIS GROUP NV : Biocartis Announces Presentation of First Prospective Vali..
21/04PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Reports Results of First Quarter of 2022: On ..
21/04Biocartis Group NV Reconfirms Earnings Guidance of 2022
12/04PRESS RELEASE BIOCARTIS GROUP NV : Invitation to the Annual Shareholders' Meeting
31/03PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Publication of 2021 Annual Report
24/02BIOCARTIS : Webcast presentation full year 2021 results
24/02TRANSCRIPT : Biocartis Group NV, 2021 Earnings Call, Feb 24, 2022
24/02BOLSA DE MADRID : La incursión de Putin en Ucrania hace caer los mercados
24/02Le raid de Poutine sur l'Ukraine culbute les marchés
24/02AVIS D'ANALYSTES DU JOUR : Carrefour, Eurofins, Faurecia, VAT Group, Paradox, Campari, Ele..
24/02BIOCARTIS : Announces 2021 results and 2022 outlook
24/02PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 results and 2022 outlook
24/02Biocartis Group NV Reports Earnings Results for the Full Year Ended December 31, 2021
24/02Biocartis Group NV Provides Earnings Guidance for the Year 2022
24/02PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 results and 2022 outlook
17/02BIOCARTIS : Announces 2021 full year results on 24 february 2022
17/02PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces 2021 full year results on 24 febru..
08/02Biocartis, Ophiomics to Jointly Commercialize Liver Cancer Test
08/02PRESS RELEASE BIOCARTIS GROUP NV : Biocartis and Ophiomics to Collaborate on Liver Cancer..
08/02Biocartis and Ophiomics to Collaborate on Liver Cancer Test
04/02PRESS RELEASE BIOCARTIS GROUP NV : Disclosure of a transparency notification
25/01Biocartis' Lung Cancer Test Shown to Improve Patient Survival Rates in UK Study
25/01PRESS RELEASE BIOCARTIS GROUP NV : Large UK Study Shows Rapid EGFR Testing with Idylla&tra..
25/01Biocartis Group NV Announces Publication of Large New Study Comparing the Difference in..
13/01BOLSA DE MADRID : ŅPreparado para el nuevo mundo?
13/01Prêt pour le monde d'après ?
13/01AVIS D'ANALYSTES DU JOUR : Stellantis, Vinci, STMicroelectronics, Soitec, ABB, Asos, Nokia..
10/01BIOCARTIS : Meets 2021 key objectives
10/01PRESS RELEASE BIOCARTIS GROUP NV : Biocartis meets 2021 key objectives
2021Biocartis' COVID-19 Tests Found to Detect Omicron Variant
2021PRESS RELEASE BIOCARTIS GROUP NV : Biocartis' Idylla™ SARS-CoV-2 testing Successfull..
2021Biocartis’ Idylla™ SARS-CoV-2 Testing Successfully Detects Omicron Variant
2021PRESS RELEASE BIOCARTIS GROUP NV : SeptiCyteģ RAPID Receives 510(k) clearance by US FDA
2021Biocartis Group NV Announces SeptiCyte? Rapid Receives 510(K) Clearance by US FDA
2021Biocartis' Epidermal Growth Factor Receptor Mutation Test Shows Reduced Patient Managem..
2021PRESS RELEASE BIOCARTIS GROUP NV : New Study Demonstrates Idylla™ EGFR Mutation Test..
2021Biocartis Group NV Announces the Publication of New Study that Demonstrates That the Id..
2021PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Q3 2021 Business Update
2021BIOCARTIS : Disclosure of a transparency notification
2021PRESS NEWS BIOCARTIS GROUP NV : Disclosure of a transparency notification
2021BIOCARTIS : Restarts Production Of ML2 Manufacturing Line
2021BIOCARTIS : Announces Restart of its High-Throughput Cartridge Manufacturing Line
2021PRESS RELEASE BIOCARTIS GROUP NV : Biocartis Announces Restart of its High-Throughput Cart..
2021Biocartis Group NV Announces Restart of Its High-Throughput Cartridge Manufacturing Lin..
2021BIOCARTIS : Disclosure of a transparency notification
2021PRESS RELEASE BIOCARTIS GROUP NV : Disclosure of a transparency notification
2021BIOCARTIS : Webcast presentation H1 2021 results
2021TRANSCRIPT : Biocartis Group NV, H1 2021 Earnings Call, Sep 02, 2021
2021BIOCARTIS : Launches Idylla™ SARS-CoV-2/Flu/RSV Panel
2021BIOCARTIS : announces H1 2021 results
2021PRESS RELEASE BIOCARTIS GROUP NV : Biocartis announces H1 2021 results
2021Biocartis Group Nv Reports Earnings Results for the Half Year Ended June 30, 2021
2021PRESS NEWS BIOCARTIS GROUP NV : Biocartis Launches Idylla™ SARS-CoV-2/Flu/RSV Panel
2021Biocartis Group NV Launches Idyllaô SARS-CoV-2/Flu/RSV Panel
2021BIOCARTIS : Disclosure of a transparency notification
2021PRESS RELEASE BIOCARTIS GROUP NV : Disclosure of a transparency notification
2021BIOCARTIS : Announces 2021 half-year results on 2 september 2021
1  2  3  4  5  6  7  8Volgende
Volgende evenement op BIOCARTIS GROUP NV